These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20806684)

  • 1. Crossing the finish line: follow-up of abnormal test results in a multisite community health center.
    Chen ET; Eder M; Elder NC; Hickner J
    J Natl Med Assoc; 2010 Aug; 102(8):720-5. PubMed ID: 20806684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of timely follow-up after abnormal cancer screening among women seeking care at urban community health centers.
    Battaglia TA; Santana MC; Bak S; Gokhale M; Lash TL; Ash AS; Kalish R; Tringale S; Taylor JO; Freund KM
    Cancer; 2010 Feb; 116(4):913-21. PubMed ID: 20052731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family planning provider referral, facilitation behavior, and patient follow-up for abnormal Pap smears.
    Felix HC; Bronstein J; Bursac Z; Stewart MK; Foushee HR; Klapow J
    Public Health Rep; 2009; 124(5):733-44. PubMed ID: 19753952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast and cervical cancer screening in obese minority women.
    Ferrante JM; Chen PH; Jacobs A
    J Womens Health (Larchmt); 2006 Jun; 15(5):531-41. PubMed ID: 16796480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
    Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
    JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence characteristics after abnormal screening results between mammogram and Papanicolaou test groups.
    Fang SY; Shu BC
    Cancer Nurs; 2009; 32(6):437-45. PubMed ID: 19816157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
    Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
    MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
    J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening mammography and Pap tests among older American women 1996-2000: results from the Health and Retirement Study (HRS) and Asset and Health Dynamics Among the Oldest Old (AHEAD).
    Ostbye T; Greenberg GN; Taylor DH; Lee AM
    Ann Fam Med; 2003; 1(4):209-17. PubMed ID: 15055410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammograms and Pap smears for Australian deaf women.
    Wollin J; Elder R
    Cancer Nurs; 2003 Oct; 26(5):405-9. PubMed ID: 14710803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    Melnikow J; Chan BK; Stewart GK
    Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.
    Carrasco-Garrido P; Hernandez-Barrera V; Lopez de Andres A; Jimenez-Trujillo I; Gallardo Pino C; Jimenez-Garcıa R
    Eur J Public Health; 2014 Apr; 24(2):264-70. PubMed ID: 23813710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a breast and cervical cancer screening program in a public hospital emergency department. Cancer Control Center of Harlem.
    Mandelblatt J; Freeman H; Winczewski D; Cagney K; Williams S; Trowers R; Tang J; Kerner J
    Ann Emerg Med; 1996 Nov; 28(5):493-8. PubMed ID: 8909269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mammography, Pap test and prostate examination by body mass index during the developmental period of cancer screening in Estonia.
    Tekkel M; Veideman T; Rahu M
    Public Health; 2011 Oct; 125(10):697-703. PubMed ID: 21907366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of ENCOREplus. A community-based breast and cervical cancer screening program.
    Fernandez ME; DeBor M; Candreia MJ; Wagner AK; Stewart KR
    Am J Prev Med; 1999 Apr; 16(3 Suppl):35-49. PubMed ID: 10198679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
    Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
    Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the social gradients for Pap smears and mammograms in Argentina: evidence from the 2005 and 2009 National Risk Factor Surveys.
    De Maio FG; Linetzky B; Ferrante D
    Public Health; 2012 Oct; 126(10):821-6. PubMed ID: 23083845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and missed opportunities in breast and cervical cancer screening among women aged 50 and over, New York City, 2002.
    Nash D; Chan C; Horowitz D; Vlahov D
    J Womens Health (Larchmt); 2007; 16(1):46-56. PubMed ID: 17324096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of follow-up of prostate-specific antigen test results.
    McFall SL; Smith DW
    Public Health Rep; 2009; 124(5):718-25. PubMed ID: 19753950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center.
    McKee MD; Lurio J; Marantz P; Burton W; Mulvihill M
    Arch Fam Med; 1999; 8(2):129-34. PubMed ID: 10101983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.